Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 3230-3240
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3230
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3230
Figure 6 Aldehyde dehydrogenase 2 family member-deficiency leads to accumulated acetaldehyde and increased DNA damage in vivo.
A: The tumor growth in xenograft tumor mice model; B: The tumor volumes in shRNA aldehyde dehydrogenase 2 family member-SK-CO-1 mouse xenograft models treatment of imatinib; C: The mice were killed, and the tumor weight was assessed; D: Relative quantification of acetaldehyde of mice tumor tissues; E: Detection of Bax, Bcl-2, γH2AX, p-JNK/JNK, and p-P38 MAPK/P38 MAPK protein levels in tumor tissue by western blot. Results are the mean ± SD of triplicate samples. t-test, cP < 0.001.
- Citation: Yu M, Chen Q, Lu YP. Aldehyde dehydrogenase 2 family member repression promotes colorectal cancer progression by JNK/p38 MAPK pathways-mediated apoptosis and DNA damage. World J Gastrointest Oncol 2024; 16(7): 3230-3240
- URL: https://www.wjgnet.com/1948-5204/full/v16/i7/3230.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.3230